Papers: 20 May 2013 - 27 May 2013
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
Endovascular diagnosis and management of chronic cerebrospinal venous insufficiency: retrospective analysis of 30-day morbidity and mortality in 95 consecutive patients.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis.
First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.
A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis.
Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
MRI and magnetic resonance angiography findings in patients with multiple sclerosis mimicked by stroke.
Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis.
Changing associations between cognitive impairment and imaging in multiple sclerosis as the disease progresses.
Application of the fuzzy logic concept in the multiple sclerosis functional composite for scoring the progress of multiple sclerosis.
Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population.
Generic quality of life burden of multiple sclerosis as compared to other debilitating chronic conditions.
Systematic review of pharmacologic therapies for neuropathic pain associated with stroke, HIV, trauma, and multiple sclerosis.
Impact on health-related quality of life in multiple sclerosis patients due to a managed care program in Colombia.
Comparing adherence rates to disease modifying therapies for multiple sclerosis in commercial enrollees and Part D beneficiaries.
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis.
Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.